# Potential Role of Donor-derived Cell-Free DNA as a Biomarker in Cardiac Allograft Vasculopathy

> **NCT04791852** · — · COMPLETED · sponsor: **Puerta de Hierro University Hospital** · enrollment: 94 (actual)

## Conditions studied

- Cardiac Allograft Vasculopathy

## Interventions

- **DIAGNOSTIC_TEST:** Donor-derived Cell Free DNA

## Key facts

- **NCT ID:** NCT04791852
- **Lead sponsor:** Puerta de Hierro University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-10
- **Primary completion:** 2021-01-31
- **Final completion:** 2021-04-15
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2021-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04791852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04791852, "Potential Role of Donor-derived Cell-Free DNA as a Biomarker in Cardiac Allograft Vasculopathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04791852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*